Tasly’s announcement on daily operating related transactions expected to occur in 2026

Securities code: 600535 Securities abbreviation: Tasly Number: Lin No. 2025-075

Tasly Pharmaceutical Group Co., Ltd.

Announcement on daily operating related transactions expected to occur in 2026

The company's board of directors and all directors guarantee that the contents of this announcement do not contain any false records, misleading statements or major omissions, and bear individual and joint liability for the authenticity, accuracy and completeness of its contents.

Important content reminder:

 This routine related transaction still needs to be submitted to the shareholders' meeting for review.

 This daily related transaction is necessary for production and operation and plays a positive role in ensuring the stability of the company's production and operation. Related party transactions follow the principles of fairness, impartiality and openness. The price of related party transactions is determined through negotiation with reference to market pricing. The pricing method is fair and reasonable. The approval procedures are performed in strict accordance with relevant regulations. It will not have an adverse impact on the company's independence and the company will not become dependent on related parties.

1. Basic situation of daily related transactions

(1) Review procedures for the performance of daily related transactions

The company's third special meeting of independent directors in 2025 reviewed and approved the "Proposal on Daily Operating Related Transactions Expected to Occur in 2026". It is believed that the company's daily related transactions with related parties in 2026 are in line with the company's normal business needs, are necessary for production and operations, and have played a positive role in ensuring the stability of the company's production and operations. Related transactions follow the principles of fairness, justice and openness. Related transaction prices are negotiated and determined with reference to market pricing. The pricing method is fair and reasonable, and the approval procedures are performed in strict accordance with relevant regulations. It will not have an adverse impact on the company's independence. The company will not become dependent on related parties. There will be no harm to the interests of the company and all shareholders, especially small and medium-sized shareholders. It was unanimously agreed to submit the proposal to the company's board of directors for review.

The 16th meeting of the ninth board of directors held on December 9, 2025 reviewed and approved the "Proposal on Daily Operating Related Transactions Expected to Occur in 2026", regarding the transactions with China Resources (Group) Co., Ltd. and its subsidiaries in 2026 For the daily operating related transactions expected to occur in the year, the related directors Ms. Zhou Hui, Mr. Mai Yi, Mr. Wang Liang, Mr. Wang Ke, Mr. Yu Xiang, Mr. Zhong Jiang, Mr. Yuan Jing and Mr. Cai Jinyong abstained from voting, and the voting results were 7 votes in favor, 0 votes against, and 0 abstentions. Regarding the daily operating related transactions expected to occur in 2026 with Tasly Biopharmaceutical Industry Group Co., Ltd. and its concerted parties, the related director Mr. Li Kexin abstained from voting, and the voting results were 14 votes in favor and 0 votes against. 0 votes, 0 abstentions. After being reviewed and approved by the non-related directors, this proposal still needs to be submitted to the company's sixth extraordinary shareholders' meeting in 2025 for review.

The "Proposal on Daily Operating Related Transactions Expected to Occur in 2026" was submitted to the public on the same day.

The 10th meeting of the 9th Board of Supervisors of the Company reviewed the matters concerning the relationship with China Resources (Group) Co., Ltd. and its subsidiaries.

For daily operating related transactions expected to occur in 2026, related supervisors Mr. Shao Jinfeng, Ms. Li Ling,

Ms. Lin Lifang abstained from voting. In view of the fact that less than half of the non-related supervisors are, she directly submitted the company's sixth meeting in 2025.

Deliberation at the extraordinary shareholders' meeting; Regarding matters with Tasly Biopharmaceutical Industry Group Co., Ltd. and its persons acting in concert

For daily operating related transactions expected to occur in 2026, the voting results were 5 votes in favor and 0 votes against.

0 abstentions. After being reviewed and approved by the non-related supervisors, this proposal still needs to be submitted to the company’s sixth interim stock meeting in 2025.

Eastern Conference review.

(2) Estimation and execution of daily related transactions in 2025

Unit: 10,000 yuan

As of October 2025 Preliminary 2025

Related Person Related Transaction Category Actual Amount on Month 31

Amount of production (Note) China Resources Pharmaceutical Group Co., Ltd. and its subsidiaries 5,000.00 4,493.21

Accept labor services

Other enterprises controlled by the same ultimate controller 3,000.00 1,388.69

or purchase goods

Subtotal 8,000.00 5,881.90

China Resources Pharmaceutical Commercial Group Co., Ltd. 15,000.00 3,977.56 China Resources Group

China Resources Henan Pharmaceutical Co., Ltd. 15,000.00 7,113.45 and its subsidiaries

China Resources Tianjin Pharmaceutical Co., Ltd. 10,000.00 2,825.17 Company Sales to related parties

China Resources Cube Pharmaceutical (Anhui) Co., Ltd. 10,000.00 3,800.48

products, commodities

China Resources Pharmaceutical Group Co., Ltd. and its subsidiaries 70,000.00 34,810.07 Other enterprises controlled by the same ultimate controller 2,000.00 79.15

Subtotal 122,000.00 52,605.88

Tianjin Tianshili Property Management Co., Ltd. 1,790.05 771.04 Tianjin Tasly Service Management Group Co., Ltd. 826.66 602.46 Yunnan Tasly Di Boer Biological Tea Group Co., Ltd. and

5,764.83 738.57 Its affiliated enterprises

Guizhou Guotai Wine Sales Co., Ltd. 6,746.01 1,894.30 Tasly Production Qinhuangdao Jinshitong International Winery Co., Ltd. 1,398.70 74.70 Industry Group and Tianjin Tasly Traditional Chinese Medicine Resources Technology Development Co., Ltd. and accepting labor services

1,919.77 558.67 Its counterparts, its subsidiaries or purchased goods

Moving Liaoning Tasly Health Products Co., Ltd. 4,399.58 550.35 Juzhi Health Technology Service Group Co., Ltd. 625.73 133.53 Tianjin Tasly Mineral Spring Beverage Sales Co., Ltd. 3,128.67 2,339.54 Tianjin Tasly Health Products Co., Ltd. 1,955.47 219.54 Anguo Digital Traditional Chinese Medicine City Co., Ltd. 1,000.00 873.28 Controlled by Tasly Health Industry Investment Group Co., Ltd. 6,000.00 3,943.09

of other companies

Subtotal 35,555.47 12,699.07

Fatai (Tianjin) Technology Co., Ltd. Receiving labor services 7,084.99 682.27 Subtotal Or purchasing equipment 7,084.99 682.27 Tasly Biopharmaceutical Industry Group Co., Ltd. Housing and transportation 500.00 127.90 Subtotal Tool rental 500.00 127.90

Note: As of October 31, 2025, the actual amount incurred by the company and China Resources Group and its subsidiaries represents the change of control of the company.

The amount incurred between March 27, 2025 and October 31, 2025.

(3) Estimated amount and types of daily related transactions expected to occur in 2026

Unit: 10,000 yuan

As of 2025, the expected share of the gold industry in October 2025 will be related to the actual amount of the previous year.

Related party ratio Actual amount incurred on 31st Transaction category Amount

Example Amount incurred Example Large difference

(%) (Note) (%) Reasons China Resources Liaoning Pharmaceutical Co., Ltd. 3,400.00 1.44 3,116.14 2.17 - China Resources Shandong Pharmaceutical Co., Ltd. 2,000.00 0.85 1,136.17 0.79 - Yunnan Shenghuo Sanqi Pharmaceutical Co., Ltd. Accepted labor 2,600.00 1.10 - - -Shenzhen Jiuxing Printing and Packaging Group Co., Ltd. service

3,309.73 1.40 147.35 0.10 - Company or Procurement

Other commodities controlled by the same ultimate controller

4,915.35 2.08 1,482.24 1.03 -China Resources Enterprise

Group Subtotal 16,225.08 6.86 5,881.90 4.10 -

and China Resources Henan Pharmaceutical Co., Ltd. 20,000.00 2.19 7,113.45 1.06 - Subsidiary China Resources Pharmaceutical Commercial Group Co., Ltd. 10,000.00 1.10 3,977.56 0.59 - Company China Resources Cubic Pharmaceutical (Anhui) Co., Ltd.

Related parties 10,000.00 1.10 3,800.48 0.56 - Division

people selling

China Resources Tianjin Pharmaceutical Co., Ltd. 10,000.00 1.10 2,825.17 0.42 -

products,

China Resources Jilin Pharmaceutical Co., Ltd. 6,916.52 0.76 3,001.59 0.45 -

merchandise

Others controlled by the same ultimate controlling party

68,083.47 7.47 31,887.63 4.73 -Enterprise

Subtotal 125,000.00 13.72 52,605.87 7.81

Tianjin Tasly mineral drink sales

4,074.02 1.72 2,339.54 1.63 - Co., Ltd.

Tianshi

Gansu Zhijiao Pharmaceutical Co., Ltd. 3,726.81 1.58 2,603.12 1.81 -Lida accepts labor

Guizhou Guotai Liquor Sales Co., Ltd. 3,539.82 1.50 1,894.30 1.32 -Health service

Tianjin Tasly Health Products Sales Co., Ltd.

and or procurement 2,341.31 0.99 865.26 0.60 Supplier Adjustment Co., Ltd.

Subordinate products

Tasly Health Industry Investment Group

Company 5,401.10 2.28 4,996.85 3.48

Other companies controlled by the company

Subtotal 19,083.07 8.07 12,699.07 8.85 -

Acceptance of labor Estimated project Jianfa Tai (Tianjin) Technology Co., Ltd. 3,016.14 1.28 682.27 0.48

Service services are expected to be added or purchased

Subtotal 3,016.14 1.28 682.27 0.48 -

Equipment

Tasly Biopharmaceutical Industry Group has housing and

872.99 58.20 127.90 15.58 - Co., Ltd. and its subsidiaries Transportation Engineering

Subtotal Tool rental 872.99 58.20 127.90 15.58 -

Note: The actual amount incurred between the company and China Resources Group and its subsidiaries as of October 31, 2025 is the amount incurred from the date of change of control of the company (March 27, 2025) to October 31, 2025.

2. Introduction of related persons and related relationships

(1) Basic information and relationships of related parties

1. China Resources Pharmaceutical Group Co., Ltd.

Related party name China Resources Pharmaceutical Group Co., Ltd.

Related party relationship: Commonly controlled by the actual controller, China Resources Co., Ltd.

Type of business Public company limited by shares

Date of establishment: May 10, 2007

Registered address: Room 4104-05, 41st Floor, China Resources Building, 26 Harbor Road, Wan Chai, Hong Kong

Registered capital HKD 27,241,288,800

Legal representative Bai Xiaosong

Mainly engaged in the research and development, manufacturing, distribution and retail of pharmaceuticals and other health products. The company mainly uses

Three major divisions operate. The Pharmaceutical segment develops, manufactures and sells pharmaceutical and nutraceutical products. Main business of pharmaceutical distribution segment

Providing distribution solutions to pharmaceutical manufacturers and dispensers, such as hospitals and other medical institutions, distributors and

Retail pharmacies. The Pharmaceutical Retail segment operates retail pharmacies in Mainland China and Hong Kong.

Financial status as of December 31, 2024 (audited)

Total assets/100 million yuan 2,577.60 Asset-liability ratio 61.95% Total liabilities/100 million yuan 1,596.73 Operating income/100 million yuan 2576.73 Net assets/100 million yuan 980.87 Net profit/100 million yuan 83.55

2. China Resources Pharmaceutical Commercial Group Co., Ltd.

Related party name China Resources Pharmaceutical Commercial Group Co., Ltd.

Related party relationship: Commonly controlled by the actual controller, China Resources Co., Ltd.

Business Type Other Limited Liability Company

Date of establishment December 27, 2000

Registration address: No. 257, Andingmennei Street, Dongcheng District, Beijing

Registered capital 19,646,531,400 RMB

Legal representative Wu Jianjun

Licensed items: pharmaceutical wholesale; agency accounting; Internet information services; third-class medical device operations; road cargo transportation (excluding dangerous goods); catering services; food sales. (Projects that require approval according to law can only be carried out after approval by relevant departments. Specific business projects are subject to approval documents or licenses from relevant departments.) General items: Sales of Class I medical devices; Sales of Class II medical devices; Technology import and export; Import and export of goods; Packaging services; Railway transportation auxiliary activities; Domestic cargo transportation agency; Supply chain management services; Sales of daily necessities; Retail sales of cosmetics; Retail sales of computer software, hardware and auxiliary equipment; Sales of electronic products; Retail sales of hardware products; Sales of household appliances; Sales of pharmaceutical special equipment; Sales of office supplies. Main business sales; office equipment sales; furniture sales; socioeconomic consulting services; hospital management; conference and exhibition services; advertising production; advertising design, agency; advertising release; financial consulting; software development; data processing services; technical services, technology development, technology consulting, technology exchange, technology transfer, technology promotion; health Health consulting services (excluding diagnosis and treatment services); information system integration services; loading and unloading; general cargo warehousing services (excluding hazardous chemicals and other items requiring license approval); sales of sanitary products and disposable medical supplies; sales of disinfectants (excluding hazardous chemicals); retail of pet food and supplies; wholesale of cosmetics. (Except for projects that require approval according to law, business activities can be carried out independently with a business license and in accordance with the law) (You are not allowed to engage in business activities that are prohibited or restricted by national and city industrial policies.)

Financial status as of December 31, 2024 (audited)

Total assets/100 million yuan 569.80 Asset-liability ratio 50.97%

Total liabilities/100 million yuan 290.45 Operating income/100 million yuan 180.22

Net assets/100 million yuan 279.35 Net profit/100 million yuan 16.54

3. China Resources Henan Pharmaceutical Co., Ltd.

Related party name China Resources Henan Pharmaceutical Co., Ltd.

Related party relationship: Commonly controlled by the actual controller, China Resources Co., Ltd.

Business Type Limited Liability Company

Date of establishment: May 25, 2009

Registration address: No. 1639, Haihang East Road, Zhengzhou Economic and Technological Development Zone

Registered capital 2.1914968 million yuan

Legal representative Li Hefeng

Licensed items: wholesale of medicines; retail of medicines; business of veterinary medicines; business of third-category medical devices; sales of food; installation, modification and repair of special equipment; road cargo transportation (excluding dangerous goods); import and export of medicines; wholesale of pesticides; retail of pesticides; technical services for maternal and infant health care; Internet information services; second-category value-added telecommunications services; traditional Chinese medicine drinks Frying service; Internet sales of food; leasing of third-class medical devices (projects that are subject to approval according to law can only be carried out after approval by relevant departments. Specific business projects are subject to approval documents or licenses from relevant departments). General projects: sales of food additives; sales of first-class medical devices; business scope of second-class medical devices Sales; sales of health food (prepackaged); sales of formulas for special medical purposes; sales of infant formula milk powder and other infant formulas; sales of disinfectants (excluding hazardous chemicals); wholesale of cosmetics; retail of cosmetics; sales of daily necessities; wholesale of daily necessities; sales of daily necessities; computer software and hardware Wholesale of accessories and auxiliary equipment; retail of computer software, hardware and auxiliary equipment; general mechanical equipment installation services; sales of electrical equipment; sales of mechanical and electrical equipment; information consulting services (excluding licensing information consulting services); marketing planning; market research (excluding foreign-related investigations); consulting and planning services; loading and unloading Transportation; conference and exhibition services; import and export of goods; technology import and export; technical services, technology development, technical consultation, technology exchange, technology transfer, technology promotion; repair of special equipment; repair of electrical equipment; repair of general equipment; sales of sanitary pesticides; sales of special chemical products (excluding hazardous chemicals) Sales of technical glass products; sales of teaching models and teaching aids; manufacturing of smart home consumer equipment; sales of household appliances; sales of plastic packaging containers and tools for food; sales of office supplies; sales of office equipment; sales of intelligent material handling equipment; sales of information security equipment; sales of agricultural and sideline products; chemical products Sales (excluding licensed chemical products); non-residential real estate leasing; machinery and equipment leasing; warehousing equipment leasing services; transportation equipment leasing services; business management; human resources services (excluding employment agency activities and labor dispatch services); health consulting services (excluding diagnosis and treatment services); remote health management services services; health care services (non-medical); traditional Chinese medicine health care services (non-medical); data processing services; artificial intelligence public data platform; big data services; data processing and storage support services; information system integration services; information technology consulting services; supply chain management services; general cargo warehousing services (not Contains hazardous chemicals and other items that require license approval); low-temperature warehousing (excluding hazardous chemicals and other items that require license and approval); food import and export; Class I medical device leasing; Class II medical device leasing; pet food and supplies wholesale; pet food and supplies retail; packaging services; optical instrument manufacturing; light Sales of learning instruments; wholesale of kitchen utensils, sanitary ware and daily necessities; sales of new energy vehicles; sales of new cars; sales of used cars; sales of plastic products; sales of rubber products; sales of labor protection supplies; sales of instruments and meters (except for items that require approval according to law, business activities can be carried out independently with a business license in accordance with the law)

Financial status as of December 31, 2024 (audited)

Total assets/100 million yuan 125.40 Asset-liability ratio 79.18%

Total liabilities/100 million yuan 99.29 Operating income/100 million yuan 185.62

Net assets/100 million yuan 26.10 Net profit/100 million yuan 2.47

4. China Resources Tianjin Pharmaceutical Co., Ltd.

Related party name China Resources Tianjin Pharmaceutical Co., Ltd.

Related party relationship: Commonly controlled by the actual controller, China Resources Co., Ltd.

Enterprise type limited liability company (sole proprietorship of legal person)

Date of establishment: March 10, 2003

Registration address: No. 408-1, Jinzhonghe Street, Wangchuanchang Street, Hebei District, Tianjin

Registered capital 842.12 million yuan

Legal representative Zhang Jinquan

Licensed items: Wholesale of medicines; business of third-category medical devices; food sales; import and export of medicines; road cargo transportation (excluding dangerous goods); production of paper packaging and container products for food; production of plastic packaging containers and tool products for food; leasing of third-category medical devices. (Projects that require approval according to law can only be carried out with the approval of relevant departments. Specific business projects are subject to the approval documents or licenses of relevant departments) General projects: import and export of goods; import and export of technology; sales of first-class medical devices; sales of second-class medical devices; sales of metal products; wholesale of sporting goods and equipment; retail of sporting goods and equipment; sales of household appliances; kitchenware business scope

Wholesale of sanitary ware and daily sundries; sales of daily chemical products; sales of office supplies; sales of daily sundries; sales of daily necessities; sales of chemical products (excluding licensed chemical products); sales of electronic products; wholesale of clothing and apparel; retail of clothing and apparel; wholesale of shoes and hats; retail of shoes and hats ; General cargo warehousing services (excluding hazardous chemicals and other items that require license approval); low-temperature warehousing (excluding hazardous chemicals and other items that require license and approval); conference and exhibition services; marketing planning; cosmetics retail; cosmetics wholesale; information consulting services (excluding hazardous chemicals and other items that require license approval); Information consulting services); etiquette services; labor services (excluding labor dispatch); technical services, technology development, technology consulting, technology exchanges, technology transfer, technology promotion; medical packaging material manufacturing; machinery equipment leasing; health consulting services (excluding diagnosis and treatment services); supply chain management services; sales of pharmaceutical special equipment; sales of machinery and equipment; repair of special equipment; wholesale of computer software, hardware and auxiliary equipment; retail of computer software, hardware and auxiliary equipment; software sales; car sales; sales of teaching models and teaching aids; sales of agricultural and sideline products. (Except for projects that require approval according to law, business activities can be carried out independently with a business license and in accordance with the law)

Financial status as of December 31, 2024 (audited)

Total assets/100 million yuan 69.60 Asset-liability ratio 81.58%

Total liabilities/100 million yuan 56.78 Operating income/100 million yuan 94.01

Net assets/100 million yuan 12.82 Net profit/100 million yuan 1.30

5. China Resources Cube Pharmaceutical (Anhui) Co., Ltd.

Related party name China Resources Cube Pharmaceutical (Anhui) Co., Ltd.

Related party relationship: Commonly controlled by the actual controller, China Resources Co., Ltd.

Business Type Other Limited Liability Company

Date of establishment: September 13, 2001

Registration address: No. 446, Wenqu Road, High-tech Zone, Hefei City

Registered capital 142.3265 million yuan

Legal representative Fan Haibo

Chinese patent medicines, Chinese medicinal materials, Chinese medicine pieces, chemical raw materials (except dangerous goods), chemical raw materials, chemical preparations, antibiotics, biochemical drugs, biological products, psychotropic drugs (limited to the second category), anabolic preparations, peptide hormones, disinfection products, chemical products (except dangerous goods), disinfection products Sales of toxic products, sanitary products, cosmetics, health products, medical devices (I, II, III), food, formula foods for special medical purposes, infant formula milk powder, infant formula foods, health foods, and cosmetics; marketing planning; warehousing services (except dangerous goods), business scope Loading and unloading services, leasing of self-owned warehouses; business information consulting services; sales of glass instruments, hardware and electrical appliances, household appliances, daily necessities, handicrafts, stationery, knitted textiles, and equipment; self-operated and agency import and export business of various commodities and technologies (except for special import and export commodities stipulated by the state and special commodities prohibited by the state); marketing services, logistics and distribution services (except express delivery); information services in the second category of value-added telecommunications services (Internet information services, excluding fixed network telephone information services). (Projects that require approval according to law can only carry out business activities after approval by relevant departments)

Financial status as of December 31, 2024 (audited)

Total assets/100 million yuan 8.80 Asset-liability ratio 72.95%

Total liabilities/100 million yuan 6.42 Operating income/100 million yuan 17.14

Net assets/100 million yuan 2.38 Net profit/100 million yuan 0.16

6. China Resources Liaoning Pharmaceutical Co., Ltd.

Related party name China Resources Liaoning Pharmaceutical Co., Ltd.

Related party relationship: Commonly controlled by the actual controller, China Resources Co., Ltd.

Business Type Other Limited Liability Company

Date of establishment: March 7, 2011

Registration address: No. 33, Nanliuma Road, Heping District, Shenyang City, Liaoning Province (Axis 1-5)

Registered capital 1.047 billion yuan

Legal representative Chen Yue

Business of Class III medical devices; Internet information services for medical devices; sales of Class II and III radiation devices; inspection and testing services; wholesale of drugs; food sales; drug Internet information services; Internet sales of food; road cargo transportation (excluding dangerous goods); sales of disinfection equipment. (Items that require approval according to law can only be carried out with the approval of relevant departments. Specific business items are subject to the approval documents or licenses of relevant departments.) General items: food sales (only sales of pre-packaged food); sales of health food (pre-packaged); sales of formula foods for special medical purposes; sales of infant formula milk powder and other infant formula foods; Internet sales of food (only sales of pre-packaged foods) packaging of food); sales of first-class medical devices; sales of second-class medical devices; wholesale of protective equipment for medical staff; wholesale of medical masks; technical services, technology development, technical consulting, technical exchanges, technology transfer, and technology promotion; conference and exhibition services; repair of special equipment; repair of instruments and meters; wholesale of cosmetics; sales of daily necessities; sales of sanitary products and disposable medical supplies; rental business scope

Rental services (excluding licensed leasing services); disinfectant sales (excluding hazardous chemicals); rehabilitation assistive device adaptation services; wholesale of sporting goods and equipment; domestic trade agents; wholesale of kitchenware, sanitary ware and daily sundries; sales of experimental analysis instruments; sales of special instruments for teaching; sales of gas, liquid separation and purification equipment; sales of daily necessities; wholesale of hardware products; sales of plastic products; sales of household appliances; sales of special chemical products (excluding hazardous chemicals); sales of optical instruments; sales of special pharmaceutical equipment Sales; loading and unloading; general cargo warehousing services (excluding hazardous chemicals and other items requiring license approval); business management; health consulting services (excluding diagnostic and treatment services); sales of office supplies; sales of office equipment; sales of office equipment and consumables; wholesale of computer software, hardware and auxiliary equipment; non-residential real estate leasing; traditional Chinese medicine clinic services (must be registered with the competent department of traditional Chinese medicine before engaging in business activities); retail of cosmetics; primary processing of edible agricultural products; wholesale of edible agricultural products; retail of edible agricultural products. (Projects that require approval according to law can only be carried out with approval from relevant departments) Financial status December 31, 2024 (audited)

Total assets/100 million yuan 47.22 Asset-liability ratio 72.72%

Total liabilities/100 million yuan 34.34 Operating income/100 million yuan 43.77

Net assets/100 million yuan 12.88 Net profit/100 million yuan 0.18

7. China Resources Shandong Pharmaceutical Co., Ltd.

Related party name China Resources Shandong Pharmaceutical Co., Ltd.

Related party relationship: Commonly controlled by the actual controller, China Resources Co., Ltd.

Business Type Other Limited Liability Company

Date of establishment: February 28, 2000

Registration address: No. 1088, Meili Road, Huaiyin District, Jinan City, Shandong Province

Registered capital 1,572.86 million yuan

Legal representative Lang Tao

Drug Internet information services; drug import and export; sales of drug precursor chemicals; drug wholesale; leasing of Class III medical equipment; sales of Class II and III radiation devices; medical device Internet information services; II. Business scope Sales of Class III, IV, and V radioactive sources; operation of Class III medical devices; road cargo transportation (excluding dangerous goods); food sales; Internet sales of food; Internet information services; decoction services of traditional Chinese medicine slices; operation of veterinary drugs; sales of sterilization equipment; sales of Class I radiation devices. (Projects that require approval according to law can only be carried out with the approval of relevant departments. Specific business projects are subject to the approval documents or licenses of relevant departments.) General projects: Class II medical equipment leasing; Class II medical device sales; health consulting services (excluding diagnosis and treatment services); Class I medical care Equipment leasing; sales of first-class medical equipment; wholesale of protective equipment for medical staff; repair of special equipment; wholesale of medical masks; software development; sales of glass fiber reinforced plastic products; retail of protective equipment for medical staff; domestic trade agency; technical services, technology development, technical consultation, technical exchange, technology Technology transfer and promotion; road cargo transportation by ordinary freight vehicles with a total mass of 4.5 tons and below (except online freight and dangerous goods); conference and exhibition services; sales of special chemical products (excluding hazardous chemicals); import and export of goods; sales of health food (prepackaged); formulas for special medical purposes Product sales; plastic product sales; food Internet sales (only sales of prepackaged food); food sales (only sales of prepackaged food); sales of infant formula milk powder and other infant formula foods; sales of daily necessities; wholesale of daily necessities; sales of daily necessities; sanitary products and disposable medical supplies Sales; Internet sales (except for the sale of goods requiring licenses); retail sales of cosmetics; sales of special labor protection products; sales of personal hygiene products; wholesale of cosmetics; sales of disinfectants (excluding hazardous chemicals); rehabilitation assistive device adaptation services; rental services (excluding licensed rental services); experimental analysis Sales of instruments; sales of instruments and meters; housing leasing; warehousing equipment leasing services; office equipment leasing services; special equipment leasing; transportation equipment leasing services; marketing planning; general cargo warehousing services (excluding hazardous chemicals and other items requiring license approval); daily groceries sales; maternal and infant supplies sales sales; sales of labor protection products; sales of needle textiles; sales of industrial textile products; sales of glass instruments; sales of agricultural and sideline products; purchase of primary agricultural products; wholesale of clothing and apparel; maintenance of electronic and mechanical equipment (excluding special equipment); sales of intelligent instruments; sales of household appliances; non-residential premises Product leasing; sales of electronic products; retail of computer software, hardware and auxiliary equipment; computer system services; information technology consulting services; sales of special electronic equipment; sales of glasses (excluding contact lenses); sales of office supplies; sales of software; sales of office equipment and consumables; car sales; sales of special equipment. (Projects that require approval according to law can only carry out business activities after approval by relevant departments)

Financial status as of December 31, 2024 (audited)

Total assets/100 million yuan 124.33 Asset-liability ratio 84.25%

Total liabilities/100 million yuan 104.75 Operating income/100 million yuan 159.39

Net assets/100 million yuan 19.58 Net profit/100 million yuan 0.82

8. China Resources Jilin Pharmaceutical Co., Ltd.

Related party name China Resources Jilin Pharmaceutical Co., Ltd.

Related party relationship: Commonly controlled by the actual controller, China Resources Co., Ltd.

Enterprise type: Limited liability company (a sole proprietorship of a legal person that is not invested or controlled by a natural person)

Date of establishment September 6, 2010

Registration address: Office Building No. 1277, Yueda Road, High-tech Development Zone, Changchun City, Jilin Province

Registered capital 575 million yuan

Legal representative Dong Fengjian

Chinese patent medicines, chemical preparations, antibiotics, biological products (except vaccines), medical toxic drugs (preparations), second-class psychotropic drugs, traditional Chinese medicine pieces, and biochemical drugs; in vitro diagnostic reagents (except for biological diagnostic reagents outside the scope of physical business that are managed according to drugs); anabolic preparations, peptide hormones, Class II medical devices (based on the Class II medical device business registration certificate), Class III medical devices (based on the medical device license). Provides pharmaceutical operation management, investment management, pharmaceutical information consulting and management services. Cosmetics, health food, native livestock products, daily necessities, sanitary products, disinfection products, chemical products (excluding flammable, explosive and dangerous goods), arts and crafts, furniture, office supplies, light textile products, building materials, electronic product distribution, conference planning consulting services, traditional Chinese medicine decoction services, pre-packaged food sales (excluding refrigerated and frozen food); Chinese medicinal materials, chemical raw materials, Sales of disposable sterile medical equipment, medical hygienic materials, medical disinfectants, chemical preparations (excluding flammable, explosive, dangerous and toxic chemicals), and office automatic equipment; warehousing services; logistics information consultation; exhibition display services; medical equipment leasing; sales of mechanical equipment and accessories, software; market research (not engaged in civil investigations, marriage investigations, whereabouts investigations, investigation and evidence collection, Debt recovery, tracing services and other investigative activities of a detective nature that endanger public interests and personal privacy); sales of Wujinjiaodian, knitted textiles, plastic products, communication equipment, computer software and hardware and auxiliary equipment, culture, sporting goods and equipment, automobiles, communication equipment, first-class medical equipment; software development; car rental; corporate-owned house rental; corporate management services Financial information consulting; Human resources management consulting; Health information consulting (not allowed to engage in diagnosis and treatment activities); Cargo transportation agency; Loading and unloading; Internet public service platform; Information processing and storage support services; Special equipment repair; Road cargo transportation (excluding dangerous goods); Liquor business (projects that require approval according to law can only be carried out with the approval of relevant departments)

Financial status as of December 31, 2024 (audited)

Total assets/100 million yuan 30.60 Asset-liability ratio 93.99%

Total liabilities/100 million yuan 28.76 Operating income/100 million yuan 32.62

Net assets/100 million yuan 1.84 Net profit/100 million yuan -0.60

9. Shenzhen Jiuxing Printing and Packaging Group Co., Ltd.

Related party name Shenzhen Jiuxing Printing and Packaging Group Co., Ltd.

Related party relationship: Commonly controlled by the actual controller, China Resources Co., Ltd.

Enterprise type limited liability company (sole proprietorship)

Date of establishment September 15, 1989

Registration address: Room 601, Jiuxin Pharmaceutical Innovation R&D Building, No. 2 Kaifeng Road, Meiting Community, Meilin Street, Futian District, Shenzhen City

Registered capital 64.564 million yuan

Legal representative Liu Wenheng

General business items: production and operation of color box printing and packaging and other packaging supplies and trademark printing, design, production of domestic and foreign printed matter advertising business; 40% of products are exported. Domestic trade (except for items that require approval before registration according to laws, administrative regulations, and decisions of the State Council); operating import and export business (except for items prohibited by laws, administrative regulations, and decisions of the State Council, and restricted items must obtain a license before they can be operated); import and export business scope agency; domestic trade agency; industrial design services; general machinery and equipment installation services; sales of machinery and equipment; sales of mechanical parts and components; and social and economic consulting services. (Except for projects that require approval according to law, business activities can be carried out independently with a business license in accordance with the law) Licensed business projects: printing of packaging and decoration printed matter. (Projects that require approval according to law can only be carried out with the approval of relevant departments. Specific business projects shall be subject to the approval documents or licenses of relevant departments)

Financial status as of December 31, 2024 (audited)

Total assets/100 million yuan 7.5 Asset-liability ratio 37.07%

Total liabilities/100 million yuan 2.78 Operating income/100 million yuan 6.45

Net assets/100 million yuan 4.72 Net profit/100 million yuan 0.68

10. Yunnan Shenghuo Panax Pharmaceutical Co., Ltd.

Related party name Yunnan Shenghuo Sanqi Pharmaceutical Co., Ltd.

Related party relationship: Commonly controlled by the actual controller, China Resources Co., Ltd.

Enterprise type: Limited liability company (a sole proprietorship of a legal person that is not invested or controlled by a natural person)

Date of establishment: November 19, 2002

Registration address No. 4, Zone A, Incubation Park, Mile Food Processing Park, Miyang Town, Mile City, Honghe Hani and Yi Autonomous Prefecture, Yunnan Province

Second floor of quasi-factory building

Registered capital 137.60 million yuan

Legal representative Wang Hailong

Manufacturing of Chinese patent medicines, biological medicines, health foods, and cosmetics; processing of Chinese medicine pieces; R&D and sales of disinfection products; Chinese patent medicines, Chinese medicine pieces, biochemical drugs, chemical preparations, antibiotics, biological products, medical equipment, textiles, clothing, daily necessities, cosmetics, agricultural and sideline products, electronic products, health food

Sales of products, pre-packaged foods, and bulk foods; cultivation, acquisition and sales of traditional Chinese medicinal materials; warehousing services (risk business scope

(excluding chemicals); beauty services; health care services; health consulting services; software development; information system integration services; data processing and storage services; hosting conferences and product exhibitions; technical consultation and promotion of pharmaceuticals; market surveys (except foreign-related investigations); corporate image planning services (items subject to approval according to law)

Project, business activities can be carried out only after approval by relevant departments)

Financial status as of December 31, 2024 (audited)

Total assets/100 million yuan 3.53 Asset-liability ratio 58.92%

Total liabilities/100 million yuan 2.08 Operating income/100 million yuan 2.04

Net assets/100 million yuan 1.44 Net profit/100 million yuan 0.15

11. Tasly Biopharmaceutical Industry Group Co., Ltd.

Name of related party Tasly Biopharmaceutical Industry Group Co., Ltd.

Related relationships: Legal persons holding more than 5% of the company’s shares

Business Type Limited Liability Company

Date of establishment: March 30, 2000

Registration place Tianjin Beichen Science and Technology Park

Registered capital 800 million yuan

Legal representative Yan Kaijing

Foreign investment and holding; natural botanical medicine cultivation and related processing and separation; organizing affiliated enterprises to carry out product production, scientific research, sales, import and export business; wholesale and retail of various commodities and materials; technology development, consulting, services, transfer of biotechnology (excluding pharmaceutical production and sales) and products; leasing of self-owned equipment and houses; various economic information consultation; export business of technology developed by the enterprise and scientific research products produced; business scope The company's import business of technology, raw and auxiliary materials, mechanical equipment, instruments, and spare parts required for scientific research and production; the company's feed processing and "three to one supplement" business; mining development and operation; production of raw materials (fexofenadine hydrochloride, eszopiclone); Internet information Information services (information services other than news, publishing, education, medical equipment and electronic announcements, business coverage: Tianjin City); conference and exhibition services; tourist attraction management; tourism management services; tourism information consulting services; ticket sales and interpretation services; tourism

Development and sales of merchandise and souvenirs. (If the state has special regulations on franchises within the above business scope, it shall be handled in accordance with the regulations).

(Projects that require approval according to law can only carry out business activities after approval by relevant departments)

Financial status as of December 31, 2024 (audited)

Total assets/100 million yuan 241.01 Asset-liability ratio 49.68%

Total liabilities/100 million yuan 119.74 Operating income/100 million yuan 97.55

Net assets/100 million yuan 121.27 Net profit/100 million yuan 4.87

12. Tianjin Tasly Mineral Spring Beverage Sales Co., Ltd.

Name of related party Tianjin Tasly Mineral Spring Beverage Sales Co., Ltd.

Related relationship: Person acting in concert with a legal person holding more than 5% of the company's shares

Enterprise type limited liability company (sole proprietorship)

Date of establishment December 20, 2024

No. 17, Xianghe Road, Science and Technology Park, Tianjin Beichen Economic and Technological Development Zone, Beichen District, Tianjin (registration place of Tianjin Bosili Real Estate Development Co., Ltd.

In the company courtyard)

Registered capital 1 million yuan

Legal representative Li Zhiwen

General items: food sales (only sales of prepackaged food); daily necessities sales; conference and exhibition services; wholesale of cosmetics; sales of personal hygiene products; sales of sanitary products and disposable medical supplies; wholesale of edible agricultural products; retail of edible agricultural products; sales of agricultural and sideline products; remote health management services; sales of first-class medical devices; sales of second-class medical devices; retail of protective equipment for medical staff; management of tourist attractions; park management services; ticket agency services; business scope

Retail sales of cosmetics; import and export of goods; sales of electronic products; sales of health food (prepackaged); sales of formula foods for special medical purposes. (Except for projects that require approval according to law, business activities can be carried out independently with a business license and in accordance with the law) Licensed projects: Medical device Internet information services. (Projects that require approval according to law can only be carried out with the approval of relevant departments. Specific business projects shall be subject to the approval documents or licenses of relevant departments)

Financial data None

13. Guizhou Guotai Liquor Sales Co., Ltd.

Name of related party Guizhou Guotai Liquor Sales Co., Ltd.

Related relationship: Person acting in concert with a legal person holding more than 5% of the company's shares

Enterprise type Limited liability company (a sole proprietorship of a legal person invested or controlled by a natural person)

Date of establishment: September 4, 2001

Registration place: Maotai Town, Renhuai City, Zunyi City, Guizhou Province

Registered capital 10 million yuan

Legal representative Yan Kaijing

Businesses that are prohibited by laws, regulations, or decisions of the State Council shall not be allowed to operate; businesses that must be prohibited by laws, regulations, or decisions of the State Council shall

If licensed (approved), the business shall be operated with the permission (approval) document after being approved by the examining and approving authority; laws, regulations, and state business scope

If the court decides that no license (approval) is required, market entities can choose to operate independently. (Using the Internet to engage in: pre-

Sales of packaged food (alcohol, tea); sales of cosmetics; export trade. **)

Financial status as of December 31, 2024 (audited)

Total assets/100 million yuan 50.05 Asset-liability ratio 80.46%

Total liabilities/100 million yuan 40.27 Operating income/100 million yuan 34.72

Net assets/100 million yuan 9.78 Net profit/100 million yuan 2.51

14. Tianjin Tasly Health Products Sales Co., Ltd.

Name of related party Tianjin Tasly Health Products Sales Co., Ltd.

Related relationship: Person acting in concert with a legal person holding more than 5% of the company's shares

Enterprise type limited liability company (sole proprietorship of legal person)

Date of establishment: March 4, 2025

No. 17, Xianghe Road, Science and Technology Park, Tianjin Beichen Economic and Technological Development Zone, Beichen District, Tianjin (registration place of Tianjin Bosili Real Estate Development Co., Ltd.

In the company courtyard)

Registered capital 30 million yuan

Legal representative Li Kexin

General projects: sales of health food (prepackaged); food sales (only sales of prepackaged food); Internet sales of food (only sales of prepackaged food); health consulting services (excluding diagnosis and treatment services); remote health management services; information technology consulting services; technical services, technology development, technical consulting, Technology exchange, technology transfer, technology promotion; retail of edible agricultural products; conference and exhibition services; advertising design, agency; advertising production; wholesale of edible agricultural products; professional design services; retail of protective equipment for medical staff; tourist attraction management; park management services; ticketing agency services; goods entry business scope Export; Wholesale of cosmetics; Sales of sanitary products and disposable medical supplies; Sales of Class I medical devices; Sales of Class II medical devices; Retail sales of cosmetics; Sales of electronic products; Wholesale of daily necessities; Sales of daily necessities; Sales of disinfectants (excluding hazardous chemicals); Internet sales (except for the sale of goods requiring licenses); Sales of daily necessities; Sales of daily sundries; Wholesale of pet food and supplies; Retail of pet food and supplies. (Except for projects that require approval according to law, business activities can be carried out independently with a business license and in accordance with the law) Licensed projects: medical device Internet information services; food sales. (Except for projects that require approval according to law, business activities can be carried out independently with a business license and in accordance with the law)

Financial data None

15. Gansu Zhijiao Pharmaceutical Co., Ltd.

Related party name Gansu Zhijiao Pharmaceutical Co., Ltd.

Related relationship: Person acting in concert with a legal person holding more than 5% of the company's shares

Enterprise type: Limited liability company (a sole proprietorship of a legal person invested or controlled by a natural person)

Date of establishment: February 27, 2002

Registration place: North side of Chang'an Road, Longxi County, Dingxi City, Gansu Province

Registered capital 100 million yuan

Legal representative Li Kexin

General projects: production of traditional Chinese medicine extracts; cultivation of Chinese medicine; purchase and sale of real estate Chinese medicine (excluding Chinese medicine pieces) (except

In addition to the licensed business, you can independently operate items that are not prohibited or restricted by laws and regulations) Licensed items: pharmaceutical production; business scope

Production of tea products; production of processed grain foods; wholesale of medicines; retail of medicines (except for items that require approval according to law)

In addition, they can independently carry out business activities in accordance with the law with a business license)

Financial status as of December 31, 2024 (audited)

Total assets/100 million yuan 0.55 Asset-liability ratio 85.45%

Total liabilities/100 million yuan 0.47 Operating income/100 million yuan 0.83

Net assets/100 million yuan 0.08 Net profit/100 million yuan 0.05

16. Fatai (Tianjin) Technology Co., Ltd.

Name of related party Fatai (Tianjin) Technology Co., Ltd.

Related relationship: Person acting in concert with a legal person holding more than 5% of the company's shares

Enterprise type limited liability company (Sino-foreign joint venture)

Date of establishment: September 1, 2005

Registration place: Beichen Science and Technology Industrial Park, Tianjin New Technology Industrial Park

Registered capital HKD 10 million

Legal representative Yan Xijun

Design, research, development, sales and consultation of mechanical instruments and equipment; assembly, wholesale, retail, import and export of mechanical instruments and equipment, pharmaceutical machinery and equipment, clean engineering materials and the above-mentioned related products, and related supporting services (the import and export of the above commodities does not involve state-owned trade, import and export quota licenses, export quota bidding, export licenses and other commodities, other commodities managed under special regulations shall be handled in accordance with relevant national regulations); pharmaceutical engineering, construction engineering, mechanical and electrical business scope

Equipment (except special equipment) installation engineering, decoration engineering design, construction, and consulting; construction project management; steel structure processing (except casting and smelting) and installation; industrial equipment installation (excluding special equipment); indoor air cleanliness testing services. (Projects that require approval according to law can only carry out business activities after approval by relevant departments)

Financial status as of December 31, 2024 (audited)

Total assets/100 million yuan 1.11 Asset-liability ratio 76.58% Total liabilities/100 million yuan 0.85 Operating income/100 million yuan 0.99

Net assets/100 million yuan 0.26 Net profit/100 million yuan 0.02

(2) Analysis of the execution status and contract performance capabilities of similar related-party transactions in the previous period

The above-mentioned related parties are all established in accordance with the law, exist legally, have the ability to continue operating and perform contracts, and have good credit performance in related transactions with the company in previous years. The company's receivables from related parties are less likely to cause bad debts.

3. Main contents and pricing policies of related-party transactions

(1) Pricing policy: The daily related transactions expected to occur between the company and its subsidiaries and related parties are ongoing businesses in the company's daily production and operations. Related transactions follow the principles of fairness, justice and openness. Related transaction prices are negotiated and determined with reference to market pricing. The pricing method is fair and reasonable. Approval procedures are performed in strict accordance with relevant regulations. There is no harm to the interests of the company and other shareholders, especially small and medium-sized shareholders.

(2) Pricing basis: (1) Pricing basis for purchasing raw materials and finished products: The company reserves the right to choose other third parties to ensure that related parties provide products to the company at fair prices. Both parties negotiate pricing based on the market price of similar products. (2) Pricing basis for products sold: The pricing of the products sold by the company to affiliated enterprises is based on the price directly sold by the company to other non-affiliated dealers, deducting the corresponding expenses incurred when the original related products were sold alone. The related transaction price of the sold products is negotiated to ensure the fairness of the related transaction price and prevent the occurrence of damage to the interests of small and medium-sized shareholders.

The above-mentioned daily related-party transaction prices are determined according to the above principles. Both parties to the transaction will determine the pricing method based on the specific circumstances of the above-mentioned related-party transaction matters and make it clear in the specific related-party transaction contract. The above daily related transactions do not harm the interests of the company and shareholders, especially small and medium shareholders.

4. Purpose of related-party transactions and impact on listed companies

The related-party transactions carried out between the company and the above-mentioned related parties are transactions that occur to ensure the company's normal procurement and sales business needs, are necessary for production and operations, and are ongoing related-party transactions that play a positive role in ensuring the stable development of the company's production and operations.

The related-party transactions between the two parties were conducted fairly and equitably in accordance with market-oriented principles, safeguarding the interests of all parties. This related transaction does not affect the company's independence and does not harm the interests of the company and its shareholders, especially small and medium-sized shareholders.

Announcement is hereby made.

Tasly Pharmaceutical Group Co., Ltd. Board of Directors

December 10, 2025